Conceptual Implementation Framework for Combination Treatments

This document is a whitepaper that presents a conceptual implementation framework aimed at addressing cost-effectiveness issues associated with combination treatments, particularly in the context of cancer therapies. The framework emerges from the recognition that many combination treatments have either been withdrawn from assessment or deemed not cost-effective by the National Institute for Health and Care Excellence (NICE). It outlines the necessity for collaboration among stakeholders, including manufacturers and health organizations, to enhance patient access to these treatments. The whitepaper evaluates the existing access ecosystem and identifies critical points and decision-makers essential for implementing solutions. It also provides recommendations for stakeholders at various stages of the treatment approval process, emphasizing the importance of clear communication and collaboration. The framework serves as a starting point for discussions among relevant parties to evolve methodologies that ensure consistent access to combination treatments for patients in need.